We are live on
!
Find out more
ENZY
Enzymotec Ltd
ENZY
ENZY
Delisted
ENZY was delisted on the 10th of January, 2018.
20 hedge funds and large institutions have $40.7M invested in Enzymotec Ltd in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
5% less funds holding
Funds holding: 21 → 20 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
19% less capital invested
Capital invested by funds: $50.3M → $40.7M (-$9.59M)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Holders
20
Holders Change
-1
Holders Change %
-4.76%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$784K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$253K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$159K |
| 4 |
GP
GLG Partners
London,
United Kingdom
|
+$159K |
| 5 |
OWD
Osborn Williams & Donohoe
Cincinnati,
Ohio
|
+$118K |
Top Sellers
| 1 |
PC
Paulson & Co
New York
|
-$20.8M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$2.35M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.76M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.07M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$553K |
